Oral Cholera Vaccine (Vibrio cholerae 01 Inaba & Ogawa strains)
Indications
Oral Cholera Vaccine (Vibrio cholerae 01 Inaba & Ogawa strains) is used for:
Cholera, Protection against cholera in adult & children >2 yr.
Adult Dose
Oral
Active immunisation against cholera
Adult: For primary vaccination schedule: Given as a suspension (in doses of 3 ml, mixed with sodium hydrogen carbonate solution): 2 doses, at wkly intervals.
Complete immunisation 1 wk prior to potential exposure.
If >6 wk have elapsed between doses, primary immunisation course should be re-initiated.
A single booster dose may be given after 2 yr to maintain protection.
Child Dose
Oral
Active immunisation against cholera
Child: For primary vaccination schedule: Given as a suspension (in doses of 3 ml, mixed with sodium hydrogen carbonate solution):
2-6 yr: 3 doses, at wkly intervals;
>6 yr: 2 doses, at wkly intervals.
Complete immunisation 1 wk prior to potential exposure.
If >6 wk have elapsed between doses, primary immunisation course should be re-initiated.
A single booster dose may be given after 6 mth (2-6 yr) or 2 yr (>6 yr), depending on the age of the patient to maintain protection.
Renal Dose
Administration
Contra Indications
Hypersensitivity. Acute stomach disorder or infection w/ fever (postpone vaccination).
Precautions
Immunisation should be delayed in patients suffering from acute febrile illness or acute GI illness. Not recommended for use in children <2 yr. Limited data on efficacy and safety of the vaccine usage in HIV-infected patients. Additional protective measures should be undertaken as the vaccine does not provide complete protection against cholera infection.
Pregnancy-Lactation
Interactions
Not to be used within 3 wk of immunoglobulin admin. Reduced response may occur in patients who are concurrently receiving immunosuppressant treatment e.g. antineoplastics, corticosteroids at therapeutic doses. Oral, encapsulated typhoid vaccine should not be admin within 8 hr of cholera vaccine admin.
Side Effects
Side effects of Oral Cholera Vaccine (Vibrio cholerae 01 Inaba & Ogawa strains) :
GI disturbances, headache, dizziness and respiratory symptoms. Fever and malaise, hypersensitivity reactions and neurological symptoms.
Mode of Action
Cholera vaccine is available as oral preparations containing either live attenuated or inactivated strains. Oral cholera vaccines appear to be more effective than parenteral vaccines. It may be used in adults and children aged >2 yr who are traveling to areas of risk.